Mars Acquisition Corp. priced its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MARXU” Tuesday, February 14, 2023.
The new SPAC intends to focus on opportunities in automobiles, healthcare, financial technology, cyber security, cleantech, software, Internet and AI, specialty manufacturing and any other related technology innovations market. Mars is led by CEO and CFO Karl Brenza, COO Xiaochen (Iris) Zhao, and Chairman Shanchun Huang.
Total SPAC deal count for 2023 year-to-date is now 5. This offering is expected to close on Thursday, February 16.
Maxim Group LLC is acting as the sole book-running manager of the offering. VCL Law LLP is serving as Issuer’s Counsel with Harter Secrest & Emery LLP serving as Underwriter’s Counsel. Freed Maxick CPAs, P.C. serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...